
Master regulator of the hypothalamic-pituitary-gonadal axis — releases endogenous GnRH to restore testosterone and fertility naturally.
Ranges cited in research literature. Not a usage recommendation. For research use only.
Kisspeptin-10 is the ten-amino-acid C-terminal fragment — Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2 — of the kisspeptins, a family of peptides encoded by the KISS1 gene. The gene was discovered in 1996 in Hershey, Pennsylvania, as a metastasis suppressor in melanoma (hence the name, after Hershey's Kisses), but its central role emerged in 2003, when mutations of its receptor, KISS1R (GPR54), were found to cause hypogonadotropic hypogonadism: without a kisspeptin signal there is no puberty.
Hypothalamic kisspeptin neurons are the master switch of the reproductive axis: by activating KISS1R on GnRH neurons they trigger release of that hormone and, downstream, of LH and FSH from the pituitary and sex steroids from the gonads. They also integrate metabolic signals (leptin) and steroid feedback, which explains why the axis shuts down in malnutrition or stress. The ten-amino-acid fragment keeps full receptor affinity, with a plasma half-life of about four minutes.
In humans it has been studied in academic clinical research, mostly at Imperial College London: kisspeptin infusion raises LH in volunteers and patients, it has been used as an ovulation trigger in IVF with lower risk of hyperstimulation, and recent trials have explored its effects on brain processing of desire (JAMA Network Open, 2022). It holds no approval as a medicine in any country. Renova distributes it for research only.
| Class | Neuropeptide regulator of the hypothalamic–pituitary–gonadal axis (10-aa fragment) |
| Sequence | Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2 (10 aa) |
| CAS | 374675-21-5 |
| Gene / receptor | KISS1 (1996, Hershey PA) · KISS1R / GPR54 (mutations → hypogonadotropic hypogonadism, 2003) |
| Mechanism | Activation of GnRH neurons → LH, FSH → gonadal steroids; integrates leptin and steroid feedback |
| Half-life | ≈ 4 minutes (KP-10); KP-54 lasts ≈ 30 minutes |
| Clinical research | Imperial College: infusions, IVF ovulation trigger, brain-processing studies |
| Regulatory status | Not approved in any country |
Because the gene encoding it, KISS1, was discovered in 1996 in Hershey, Pennsylvania, the home of Hershey's Kisses chocolates, initially as a metastasis suppressor in melanoma. Seven years later its receptor was found to control the onset of puberty, and it became a central piece of reproductive endocrinology.
They are fragments of the same precursor: KP-54 is the long circulating form and KP-10 is its last ten amino acids, which suffice to activate the receptor with the same affinity. The practical difference is duration: KP-10 lasts about four minutes in plasma and KP-54 close to half an hour.
In Imperial College London trials, a single administration of kisspeptin triggered final oocyte maturation in women at high risk of ovarian hyperstimulation syndrome, with live births and no cases of severe hyperstimulation. It is a clinical-research use; it is not commercially approved.
Indirectly, through the axis: kisspeptin stimulates GnRH release, GnRH stimulates LH, and LH drives testosterone production in the testes. In infusion studies in men, LH and testosterone rose transiently. The axis keeps its feedback, so the effect is self-limiting.
Related reading: Kisspeptin-10: The Switch of the Reproductive Axis · Oxytocin: The Bonding Neuropeptide
Informational content based on published scientific literature; it is not a recommendation for use or medical advice. Product strictly for research use (RUO), not suitable for human or veterinary consumption.
Your cart is empty